Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Hidradenitis

Not recruiting

Investigational

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Investigational

Norway

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lutikizumab

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Investigational

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Enasidenib Mesilate

Contact Research Centre

Ovarian cancer

Not recruiting

Registered drugNo placebo

Study of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Alrefimotide

Contact Research Centre

Malignant melanoma stage IV+1

Not recruiting

Registered drugNo placebo

Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

Registered drugNo placebo

Norway

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

K-ras gene mutation+2

Not recruiting

Registered drugNo placebo

Study on Sotorasib for Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer and Comorbidities

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Sotorasib

Contact Research Centre

Sjogren's syndrome

Not recruiting

Registered drug

Study on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Leflunomide

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Registered drug

Study on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Florbetaben (18F)

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Talquetamab and Teclistamab in First-Line Treatment for Transplant-Eligible Multiple Myeloma Patients

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Elranatamab

Contact Research Centre

Juvenile idiopathic arthritis

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Triamcinolone Hexacetonide Injections for Juvenile Idiopathic Arthritis in Patients Starting TNF Inhibitor Treatment

Registered drugNo placebo

Norway

Participants:0–17 years
Substances:Triamcinolone Hexacetonide

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Registered drugNo placebo

Study on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis

Registered drugNo placebo

Norway

Participants:18–64 years
Substances:Adalimumab

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 9

128 trials match your criteria

Hidradenitis

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Acute myeloid leukaemia+1

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Ovarian cancer

Study of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Malignant melanoma stage IV+1

Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

K-ras gene mutation+2

Study on Sotorasib for Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer and Comorbidities

Sjogren's syndrome

Study on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome

Dementia Alzheimer's type

Study on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease

Plasma cell myeloma

Study on the Effectiveness of Talquetamab and Teclistamab in First-Line Treatment for Transplant-Eligible Multiple Myeloma Patients

Plasma cell myeloma

Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Juvenile idiopathic arthritis

Study on the Effectiveness of Triamcinolone Hexacetonide Injections for Juvenile Idiopathic Arthritis in Patients Starting TNF Inhibitor Treatment

Rheumatoid arthritis

Study on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis

Transitional cell carcinoma

Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.